Factor VII genetic polymorphism
171 Factor VII J Biol Chem 255:1242-1247.
Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, Dairou F, de Gennes JL and Caen IP. (1989) Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis
19(3): 125-130.
Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T and Heinrich PC. (1988) Recombinant human interleukin- 6 (IL-6/BSF-2/HSF) regulates the synthesis of
acute phase proteins in human hepatocytes. FEBS Lett 232:347-350
Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R and Heinrich PC. Interleukin- 6 is the major regulator of acute phase protein synthesis
in adult human hepatocytes. (1989) FEBS Letters 242:237-239
Castelli WP. (1986) The triglyceride issue: A view from Framingham. Am Heart J. 112:432-437
Cerami A, and Beutler B. (1988) The role of cachetin/TNF in endotoxic shock and cachexia. Immunol Today 9:28-31
Chen J-K, Hoshi H, and McKeehan WL. (1987) Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 84 (15):5287-5291
172
Chirgwin JM, Przybyla AE, McDonald RJ and Rutter WJ. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry
18:5294-5299.
Chodosh LA, Carthew RW, Morgan JG, Crabtree GR and Sharp PA. (1987) The adenovirus major late transcription factor activates the rat 7-fibrinogen promoter.
Science 238:3244-3250
Chodosh LA, Carthew RW and Sharp PA. (1986) A single polypeptide possesses the binding and activities of the adenovirus major late transcription factor. Mol Cell Biol 6:4723-4733
Chung DW, Chan W-Y and Davie EW. (1983) Characterization of complementary deoxyribonucleic acid coding for the chain of human fibrinogen. Biochemistry 22:3250-3256
Colton T. (1974) Statistics in medicine. Pub Little, Brown & Co, Boston, USA.
Connor JM, Fowkes PGR, Wood J, Smith FB, Donnan PT and Lowe GDO. (1992) Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 29:480- 482
Green F, Kelleher C, Temple A, Meade T and Humphries S. (1991) A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arteriosclerosis and Thrombosis 11 (3): 540-546
173
Cornelius P, Enerbàck S, Bjursell G, Olivecrona T and Pekala PH. (1986) Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. Biochem J 249:765-769
Costa RH, Grayson DR and Darnell JE Jr. (1989) Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and -antitrypsin genes. Mol Cell Biol 9:1415-1425
Courtois F, Morgan JG, Campbell LA, Fourel G and Crabtree GR. (1987) Interaction of a liver-specific nuclear factor with the fibrinogen and «i-antitrypsin promoters. Science 238:688-692
Courtois G, Baumhueter S and Crabtree GR. (1988) Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci USA 65:7937-7941
Cruickshank JK, Cooper J, Burnett M, MacDuff J and Drubra U. (1991) Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 338:842-847
Current protocols in molecular biology Vol2 Ch 12 Section 12.2.5. Eds Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. Pub Wiley Interscience
I Dalmon J, Laurent M and Courtois G (1993) The human fibrinogen promoter contains
hepatocyte nuclear factor 1-dependent interleukin-6-responsive element Mol Cell Biol 13
(2): 1183-1193
174
interleukin-1, and tumour necrosis factor stimulate the acute phase response in human
hepatoma cells in vitro. J Cell Biol 103:787-793
Darnell JE. (1982) Variety in the level of gene control in eukaryotic cells. Nature 297:365-371
Derynck RJ, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Spom MB and Goetzl ED. (1985) Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705
Dinarello CA. (1984) Interleukin-1. Rev Infect Dis 6:51
Doolittle RE. (1973) Structural aspects of the fibrinogen to fibrin conversion. Advan Protein Chem 27:1-109
Duguid JB. (1948) Thrombosis as a factor in the pathogenesis of aortic atherosclerosis. J Pathol Bacteriol 60:57-61
Emeson EE and Robertson AL. (1988) T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 130:369-376
Espevik T, Figari IS, Ranges GE and Palladino Jr MA. (1988) Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumour necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and
175
recombinant human TGF-beta 1. Immunol 140:2312-2316
Evans B, Courtois G, Kilian P, Fuller G and Crabtree GR. (1987) Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters. 262 (22): 10850-10854
Fagan K, Wilkinson I, Allen M and Brownlea S. (1988) The coagulation factor VII regulator is located on 8p23.1. Hum Genet 79:365-367
Faggioto A, Ross R, Marker L. (1984a) Studies of hypercholesterolemia in the non human primate. I. Changes that lead to fatty streak formation. Arteriolsclerosis 4:323- 340.
Faggioto A, Ross R. (1984b) Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4:341-356.
Fatah K, Hamsten A, Blomback B and Blomback M. (1992) Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. 6 8 (2): 130-135
Feinberg A, and Vogelstein B. (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 132:6-13
Fey GH and Fuller GM. (1987) Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 4:323-338
176
Flute PT. (1977) Disorders of plasma fibrinogen synthesis. Br Med Bull 33 (3):253-259
Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD and Szklo M. (1991) Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91:191-205
Fuller GM, Otto JM, Woloski BM, McGary CT and Adams MA. (1985) The effects o f hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers. J Cell Biol 101:1481-1486
Fuster V, Badimon L, Badimon JJ and Chesebro. (1992) The pathogenesis o f coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (4):242-250
Gauldie J, Richards C, Hamish D, Lansdorp P and Baumann H. (1987) Interferon jS2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte- stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84 (20):7251-7255
Gerrity RG. (1981b) The role of the monocyte in atherogenesis. II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 103:191-200.
Gerrity RG. (1981a) The role of the monocyte in atherogenesis. I. Transition of blood borne monocytes into foam cells in fatty lesions. Am J Pathol 103:181-190.
177
Jr. (1989) Functional significance of the Kunitz-type inhibitory domains of lipoprotein- associated coagulation inhibitor. Nature 338:518-520
Goodwin GH, Partington GA and Perkins ND. (1990) Sequence specific DNA binding proteins involved in gene transcription. In: Chromosomes: Eukaryotic, prokaryotic and viral (Adolph KW ed). 1:31-85. Boca Raton, Florida: CRC Press
Gordon D, Reidy MA, Benditt EP and Schwartz SM. (1990) Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600-4604
Gordon V, Innerarity TL and Mahley RW. (1983) Formation of cholesterol - and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem 258:6202-6212
Gown AM, Tsukada T, Ross R. (1986) Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125:191-207
Green F, Kelleher C, Temple A, Meade T and Humphries S. (1991) A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arteriosclerosis and Thrombosis 11 (3): 540-546
Green P, Bentley D, Mibashan R, Nilsson I and Gianelle F. (1989) Molecular pathology of haemophilia B. EMBO J 8:1067-1072.
Griffin JH, Evatt B, Zimmerman TS, Klein AJ and Wideman C. (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370-1373
Grundy SM and Mok HYI. (1976) Chylomicron clearance in normal and hyperlipidaemic men. Metabolism 25:1225
178
Gruppo Italiano per lo Studio della Sopravivenza nell’Infarto Miocardico. (1990) GISSI-
2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no
heparin among 12,490 patients with acute myocardial infarction. Lancet 336:65-71
Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W and Kurachi K. (1986) Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 83 (8):2412-2416
Hamsten A, Blomback M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L. (1986) Haemostatic function in myocardial infarction. Br Heart J 55:58-66
Hamsten A, deFaire U, Iselius L and Blomback M (1987) Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet ii:988-991
Handa K, Kono S, Sciku K, Sasaki J.Kawano T, Sasaki Y, Hiroki T, Arakawa K. (1989) Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 77:209-13
Handagama P, Rappolee DA, Werb Z, Levin J and Bainton DF. (1990) Platelet a- granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes. J Clin Invest 86:1364-1368
Hansson GK, Jonasson L, Seifert PS and Stemme S. (1989) Immune mechanisms in atherosclerosis. Arteriosclerosis 9:567-578
179
Hansson GK, Bondjers G. (1980) Endothelial cell proliferation and atherogenesis in rabbits with moderate hypercholesterolemia. Artery 7:316-329
Hansson GK, Jonasson L, Lojsted B,Stemme S, Kocher O, Gabbiani G. (1988) Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis 72:135-141
Hansson GK, Bjomheden T, Bylock A and Bondjers G. (1981) Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol 34:246-252
Hattori M, Abraham U , Northemann W and Fey GH. (1990) Acute phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin- 6
response element of the rat a2-macroglobulin gene. Proc Natl Acad Sci USA 87:2364- 2368
Haust MD, Wyllie JC, Moke RH. (1965) Electron microscopy of fibrin in human atherosclerotic lesions. Exp Mol Pathol 4:465-479
Hawrylowicz CM, Santoro SA, Platt FM and Unanue ER. (1989) Activated platelets express IL-1 activity. J Immunol 143 (12):4015-4018
Henschen A and Me Donagh J. (1986) Fibrinogen, fibrin and factor XIII. Blood Coagulation 171-239 Zwaal RFA and Hemker HC (eds) Amsterdam: Elsevier Science Publishers BV (Biomedical Division).
180
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH and Kishimoto T. (1985) Purification to homogeneity and characterization of human B-cell diifferentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82 (16):5490-5494
Hixson JE. (1991) Apolipoprotein B polymorphisms affect atherosclerosis in young males. 11 (5): 1237-1244
Hocke GM, Barry D and Fey GH. ( 1992) Synergistic action of interleukin- 6 and
glucocorticoids is mediated by the interleukin- 6 response element of the rat alpha 2
macroglobulin gene. Mol Cell Biol 12 (5): 2282-2294
Huber P, Laurent M and Dalmon J. (1990) Human /3-fibrinogen gene expression: upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. J Biol Chem 265 (10):5695-5701
Huber P, Dalmon J, Courtois G, Laurent M, Assouline Z and Marguerie G. (1987) Characterization of the 5 ’-flanking region for the human fibrinogen gene. Nucleic Acids Res 15 (4): 1615-1625
Hultin M. (1991) Fibrinogen and factor VII as risk factors in vascular disease. Prog Hemost Thromb 10:215-241
Humphries SE, Whittall R, Minty A, Buckingham M and Williamson R. (1981) Nucleic Acids Research 9:4895-4908.
181
Humphries SE. (1988) DNA polymorphisms of the apolipoprotein genes - their use in the investigation of the genetic component of hyperlipidaemiaand atherosclerosis. Atherosclerosis 72:89-108
Humphries SE, Green PR, Thomas AE, Kelleher CH and Meade TW. (1991) Genetic control of plasma fibrinogen levels: an example of gene-environment interaction in the etiology of a multifactorial disorder. Etiology of human disease at the DNA level. Eds Lindsten J and Petterson U Pub Raven Press Ltd.
Humphries SE, Cook M, Dubowitz M, Stirling Y and Meade TW. (1987) Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lemcet i: 1452-1455
Humphries SE, Imam AM A, Robbins TP, Cook M, Carritt B, Ingle C, and Williamson R. (1984) The identification of a DNA polymorphism of the a-fibrinogen genes to 4q26-qter. Hum Genet 68:148-153
Ignotz RA and Massague J. (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345
Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y and Ogawa M. (1987) Interleukin- 6
enhancement of inetrleukin-3-dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci USA 84:9035-9039
182
Imam AMA, Eaton MAW, Williamson R and Humphries S. (1983) Isolation and characterisation o f cDNA clones for the A a- and 7-chains of human fibrinogen. Nuc
Acids Res 11:7427-7434
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among
17,187 cases o f suspected acute myocardial infarction: ISIS-2) Lancet i:349-351
Ito T, Tanashi H, Misumi Y and Sakaki Y. (1989) Nuclear factors interacting with an interleukin- 6 responsive element of rat a2-macroglobulin. Nucleic Acids Res 17:9425-
9435
Jambou RC, Snouwaert JN, Bishop GA, Stebbins JR, Frelinger JA and Fowlkes DM. (1988) High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proc Natl Acad USA 85:9426-9430
Jeffreys AJ, Wilson V and Thein SL. (1985) Hypervariable ’minisatellite’ regions in human DNA. Nature 314:67-73
Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA and Lotz M. (1989) Bacterial lipopolysaccharides and inflammatory mediators augment IL- 6 secretion
by human endothelial cells. J Immunol 142:144-147
Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. (1986) Regional accumulations of T cells, macrophages and smooth muscle cells in the human
183
atherosclerotic plaque. Arteriosclerosis 6:131-138
Jonasson L, Bondjers G and Hansson GK. (1987) Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res 28:437- 445
Joris I and Majno G. (1977) Atherosclerosis and inflammation. Adv Exp Med Biol 104:227-235
Joris I, Zand T, Nunnari JJ, Krolikowski FJ, Majno G. (1983) Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta o f hypercholesterolemic rats. Am. J. Pathol. 113:341-358.
Kampschmidt RF. (1984) The numerous postulated biological manifestations of interleukin-1. J Leukocyte Biol 36:341-355
Kannel WB, Wolf PA, Castelli, WP and D ’Agostino RB. (1987) Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 258:1183-1187
Kant JA and Crabtree GR. (1983) The rat fibrinogen genes. J Biol Chem 258:4666- 4667
Kant JA, Lord ST and Crabtree GR. (1983) Partial mRNA sequences for human A a, Bj8 and 7 fibrinogen chains: evolutionary and functional implications. Proc Natl Acad
184
Kant JA, Fomace AJ Jr, Saxe D, Simon MI, McBride OW and Crabtree GR. (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acd Sci USA 82:2344-2348
Kao VCY, Wissler RW. (1965) A study of the immunohistochemical localization of serum lipoproteins and other plasma proteins in human atherosclerotic lesions. Exp Mol Pathol 4:465-479
Kerr LD, Miller DB and Matrisian LM. (1990) TGF-/31 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61:267-278
Kinoshita S, Akira S and Kishimoto T. (1992) A member of the C/EBP family, NF-IL6
j8, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad
Sci USA 89:1473-1476
Kluft C, Dooijewaard G and Emeis JJ. (1987) Role of the contact system in fibrinolysis. Sem Thromb Hemost 13:50-68
Klurfeld DM. (1985) Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch Pathol Lab Med 109:445-449
Kohase M, Henriksen-DeStefano D, May LT, Vilcek and Sehgal PB. (1986) Induction of beta 2-interferon by tumour necrosis factors: a homeostatic mechanism in the control
185
Kohase M, May LT, Tamm I, Vilcek J and Sehgal P. (1987) A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumour necrosis factor, platelet-derived growth factor and interleukin 1. Mol Cell Biol 7:273-280
Koj A. (1985) Definition and classification of acute phase proteins. In The acute phase response to injury and infection. AH Gordon and A Koj. Eds Elsevier Amsterdam 139.
Kozak M (1984) Nucleic acids research 12:857-872
Kugler W, Wagner U and Ryffel GU. (1988) Tissue-specificity of liver gene expression: a common liver-specific promoter element. Nuc Acids Res 16:3165-3174
Landschultz WH, Johnson PF, Adashi EY, Graves BJ and McKnight SL. (1988) Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2:786-8(X) Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S and Green F. (1992) Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 94:43-50
Lane A, Graham L, Cook M, Chantry D, Green F, Nigon F and Humphries SE. (1991) Cytokine production by cholesterol-loaded human peripheral monocyte-macrophages : the effect on fibrinogen mRNA levels in a hepatoma cell-line (HepG2). Biochem Biopyhs Acta 1097:161-165
Latchman DS. (1991) DNA sequences and transcription factors. In: Eukaryotic transcription factors Pub. Academic press Harcourt Brace Jovanovich London
186
Le J and Vilcek J. (1987) Tumour necrosis factor and interleukin 1: cytokines with multiple overlapping activities. Lab Invest 86:234-248
Lee KA, Binderdeif A and Green MR. (1988) A small scale procedure for preparation o f nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Techn 5:22-31.
Lee AJ, Smith WCS, Lowe GDO and Tunstall-Pedoe H. (1990) Plasma fibrinogen and coronary risk factors: the Scottish Heart Health study. J Clin Epidemiol 9:913
Libby P Ordovas JM, Birinyi LK, Auger KR and Dinarello CA. (1986). Inducible interleukin-1 expression in human vascular smooth muscle cells. J Clin Invest 78:1432-
1438
Libby P, Warner SJC, Salomon RN and Birinyi LK. (1988) Production of platelet- derived growth factor-like mitogen by smooth muscle cells from human atheroma. N Engl J Med 318:1493-1498
Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan Y-CE,Collier K, Semionow R, Chua AO and Mizel SB. (1984) Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458-462
Loppnow H and Libby P. (1990) Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 85:731-738
187
Loppnow H and Libby P. (1989) Adult human vascular endothelial cells express the IL-
6 gene differentially in response to LPS or IL-1. Cell Immunol 122:493-503
Louache F, Debili N, Cramer E, Beeton-Gorurs J and Vainchenker W. (1991) Fibrinogen is not synthesised by Human Megakaryocytes. Blood 77:311-316
Lowe GDO, Drummond MM, Lorimer AR et al. Relation between the extent of coronary artery disease and blood viscosity. Br Med J (1980) 281:673-4
Lowe GDO. (1986) Blood rheology in arterial disease. Clin Sci 71:137-46
Lowel H, Lewis M, Hormann A, Eberle E and Keil U. (1990) Morbidity and mortality o f myocardial infarction in the Augsburg MONICA study area in 1985, 1986 and 1987. Rev Epidemiol Sante Publique 38:411-417
Mackiewicz A, Ganapathi MK, Schultz D, Brabenec A, Weinstein J, Kelley MF and Kushner I. (1990) Transforming growth factor jSj regulates production of acute-phase proteins. Proc Natl Acad Sci USA 87:1491-1495
Majello B, Arcone R, Toniatti C and Ciliberto G. (1990) Constitutive and IL-6-induced
nuclear factors that interact with the human C-reactive protein promoter. EMBO J 9:457-465
Malekzadeh S, Dressier FA, Hoeg JM, Brewer HB Jr and Roberts WC. (1991) Am J Cardiol 67:1431
188
Maniatis T, Goodboum S and Fischer JA. (1987) Regulation o f inducible and tissue- specific gene expression. Science 236:1237-1245
March CJ, Moseley B, Larsen A, Ceretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TPand Cosman D. (1985) Cloning,